Principal Financial Group Inc. decreased its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 35.6% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 270,759 shares of the company’s stock after selling 149,996 shares during the period. Principal Financial Group Inc. owned 0.51% of Nu Skin Enterprises worth $16,647,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. raised its holdings in shares of Nu Skin Enterprises by 1.8% in the 2nd quarter. BlackRock Inc. now owns 6,805,093 shares of the company’s stock valued at $427,632,000 after acquiring an additional 121,562 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Nu Skin Enterprises by 0.8% in the 2nd quarter. Vanguard Group Inc. now owns 6,060,437 shares of the company’s stock valued at $380,838,000 after acquiring an additional 48,805 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Nu Skin Enterprises by 6.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,067,875 shares of the company’s stock valued at $67,106,000 after acquiring an additional 64,767 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Nu Skin Enterprises by 22.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 885,257 shares of the company’s stock valued at $55,628,000 after acquiring an additional 160,495 shares in the last quarter. Finally, Wasatch Advisors Inc. raised its holdings in shares of Nu Skin Enterprises by 3.4% in the 2nd quarter. Wasatch Advisors Inc. now owns 638,396 shares of the company’s stock valued at $40,117,000 after acquiring an additional 20,957 shares in the last quarter. 77.54% of the stock is currently owned by institutional investors and hedge funds.
Several research firms have weighed in on NUS. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Zacks Investment Research cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $62.00.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.76. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The business had revenue of $563.70 million for the quarter, compared to analyst estimates of $562.70 million. During the same period last year, the company earned $0.98 EPS. Nu Skin Enterprises’s revenue for the quarter was down 6.7% compared to the same quarter last year. equities research analysts anticipate that Nu Skin Enterprises, Inc. will post 3.23 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be given a $0.36 dividend. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.16%. Nu Skin Enterprises’s dividend payout ratio is currently 52.75%.
In other news, insider Joseph Y. Chang sold 36,503 shares of Nu Skin Enterprises stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $62.24, for a total value of $2,271,946.72. Following the sale, the insider now directly owns 66,563 shares in the company, valued at approximately $4,142,881.12. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Daniel W. Campbell sold 4,607 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $62.48, for a total value of $287,845.36. Following the completion of the transaction, the director now owns 63,753 shares of the company’s stock, valued at approximately $3,983,287.44. The disclosure for this sale can be found here. Over the last quarter, insiders sold 73,207 shares of company stock worth $4,585,949. Corporate insiders own 5.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://stocknewstimes.com/2017/12/06/principal-financial-group-inc-reduces-position-in-nu-skin-enterprises-inc-nus.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.